ArticleJournal of translational medicine2022

The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs.

Marzia Del Re et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.